• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析治疗前终末期肾病中的钙敏性血管炎:一例报告及文献综述。

Calciphylaxis in end-stage renal disease prior to dialytic treatment: a case report and literature review.

作者信息

Tamayo-Isla Ramón Alberto, Cuba de la Cruz Mauro

机构信息

Internal Medicine Department, Pietersburg Provincial Hospital, Polokwane Kidney and Dialysis Centre, Limpopo Province, South Africa.

出版信息

Int J Nephrol Renovasc Dis. 2015 Feb 13;8:13-8. doi: 10.2147/IJNRD.S78310. eCollection 2015.

DOI:10.2147/IJNRD.S78310
PMID:25709494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4334332/
Abstract

INTRODUCTION

Calciphylaxis is a rare medical condition that is usually diagnosed in patients suffering from end-stage renal disease who are already receiving renal replacement therapy and in those post-transplantation. The pathogenesis still remains to be fully elucidated; hence, the treatment is not uniform. The prognosis is generally poor. The ulcerative stage exhibits a worse prognosis than the nonulcerative one. Calciphylaxis presenting in terminal kidney disease prior to dialytic treatment has only rarely been reported.

CASE PRESENTATION

A 32-year-old female Caucasian clerk sought medical attention for increasing tiredness and lower limb skin ulcers. Polycystic kidney disease was diagnosed in her late father and two of her siblings. At the first nephrology consultation, obesity, pallor, bilateral flank masses with ballottement, and two ulcers with a dark necrotic center on the distal left leg were noted. In addition, another indurated light bluish lesion of 5 cm just above the right knee with intact skin was observed. All lesions were very tender and warm on touch. Laboratory results yielded hypercalcemia, hyperphosphatemia, anemia, and parathyroid hormone levels that were more than ten times the normal values in the patient, and with a glomerular filtration rate of 4 mL/minute. Skin biopsy confirmed the suspicion of calciphylaxis. The patient was placed on peritoneal dialysis with low Ca concentration baths, cinacalcet, and aluminum hydroxide. The results included correction of hypercalcemia, improvement of phosphate levels, and the product of both Ca and phosphate, but only a transitory decrease in serum parathyroid hormone levels. The ulcerations were completely healed after 2 months of treatment. Cinacalcet was discontinued after 18 months, but multiple large-size, nonulcerative indurated areas appeared 3 months later in the lower limbs after discontinuation of the drug. A parathyroidectomy performed 17 months later revealed a four-gland hyperplastic disease. The patient experienced relief of skin symptoms soon after the procedure and remains in a very satisfactory condition.

CONCLUSION

Calciphylaxis is a very complex clinical entity. Calciphylaxis presenting prior to dialytic treatment in end-stage renal disease is rare in the absence of a trigger. Cinacalcet and parathyroidectomy should be considered in selected patients.

摘要

引言

钙过敏是一种罕见的病症,通常在接受肾脏替代治疗的终末期肾病患者以及移植后患者中被诊断出来。其发病机制仍有待充分阐明;因此,治疗方法并不统一。总体预后较差。溃疡期的预后比非溃疡期更差。在透析治疗前的终末期肾病中出现钙过敏的情况鲜有报道。

病例报告

一名32岁的白人女性职员因日益疲劳和下肢皮肤溃疡就医。她的父亲和两个兄弟姐妹在晚年被诊断出患有多囊肾病。在首次肾病会诊时,发现患者肥胖、面色苍白、双侧腰部有肿块且有浮沉感,左腿远端有两个溃疡,溃疡中心呈暗黑色坏死,此外,右膝上方还有一个5厘米大小、质地坚硬、淡蓝色、皮肤完整的病变。所有病变触诊时都非常疼痛且发热。实验室检查结果显示患者血钙过高、血磷过高、贫血,甲状旁腺激素水平超过正常值十倍以上,肾小球滤过率为4毫升/分钟。皮肤活检证实了钙过敏的怀疑。患者接受了低钙浓度浴的腹膜透析、西那卡塞和氢氧化铝治疗。结果包括高钙血症得到纠正、血磷水平及钙磷乘积有所改善,但血清甲状旁腺激素水平仅短暂下降。治疗2个月后溃疡完全愈合。18个月后停用西那卡塞,但停药3个月后下肢出现多个大尺寸、非溃疡的硬结区域。17个月后进行的甲状旁腺切除术显示为四腺增生性疾病。手术后患者的皮肤症状很快得到缓解,目前状况非常良好。

结论

钙过敏是一种非常复杂的临床病症。在终末期肾病中,透析治疗前无诱因出现钙过敏的情况很罕见。对于特定患者应考虑使用西那卡塞和进行甲状旁腺切除术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/f19fdb39e4f0/ijnrd-8-013Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/f54a6cd6967b/ijnrd-8-013Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/8dae9263486a/ijnrd-8-013Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/46ef85a72585/ijnrd-8-013Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/4dcc5dbe877e/ijnrd-8-013Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/5b957be557d0/ijnrd-8-013Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/f19fdb39e4f0/ijnrd-8-013Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/f54a6cd6967b/ijnrd-8-013Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/8dae9263486a/ijnrd-8-013Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/46ef85a72585/ijnrd-8-013Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/4dcc5dbe877e/ijnrd-8-013Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/5b957be557d0/ijnrd-8-013Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/4334332/f19fdb39e4f0/ijnrd-8-013Fig6.jpg

相似文献

1
Calciphylaxis in end-stage renal disease prior to dialytic treatment: a case report and literature review.透析治疗前终末期肾病中的钙敏性血管炎:一例报告及文献综述。
Int J Nephrol Renovasc Dis. 2015 Feb 13;8:13-8. doi: 10.2147/IJNRD.S78310. eCollection 2015.
2
Calciphylaxis and nonhealing wounds: the role of the vascular surgeon in a multidisciplinary treatment.钙过敏症与难愈合伤口:血管外科医生在多学科治疗中的作用
J Vasc Surg. 2003 Mar;37(3):501-7. doi: 10.1067/mva.2003.70.
3
Systemic calciphylaxis in a patient with end-stage renal disease and a normal parathyroid hormone level taking erythropoietin intramuscularly.
Endocr Pract. 1999 Jan-Feb;5(1):46-50. doi: 10.4158/EP.5.1.46.
4
Regression of vascular calcification following an acute episode of calciphylaxis: a case report.钙化防御急性发作后血管钙化的消退:一例报告
J Med Case Rep. 2014 Feb 14;8:52. doi: 10.1186/1752-1947-8-52.
5
Calciphylaxis after parathyroidectomy.甲状旁腺切除术后的钙化防御。
Hemodial Int. 2017 Oct;21 Suppl 2:S62-S66. doi: 10.1111/hdi.12599.
6
Calciphylaxis following kidney transplantation: a case report.
J Med Case Rep. 2009 Nov 24;3:9297. doi: 10.1186/1752-1947-3-9297.
7
Successful treatment of calciphylaxis by a multidisciplinary approach.采用多学科方法成功治疗钙过敏症。
BMJ Case Rep. 2014 Jul 17;2014:bcr2014204354. doi: 10.1136/bcr-2014-204354.
8
Calciphylaxis: a favorable outcome with hyperbaric oxygen.钙过敏症:高压氧治疗取得良好疗效
Vasc Med. 1998;3(2):115-20. doi: 10.1177/1358836X9800300205.
9
Successful Treatment of Calciphylaxis in a Young Female With End-Stage Renal Disease on Peritoneal Dialysis With Parathyroidectomy, Intensification of Dialysis, and Sodium Thiosulphate-A Case Report and Literature Review.甲状旁腺癌相关钙化防御的治疗:甲状旁腺切除术、强化透析和硫代硫酸钠治疗腹膜透析终末期肾病年轻女性 1 例报告及文献复习
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211060580. doi: 10.1177/23247096211060580.
10
[Cutaneous calciphylaxis treated by autologous keratinocytes graft and subtotal parathyroidectomy].[自体角质形成细胞移植和甲状旁腺次全切除术治疗皮肤钙化防御]
Ann Dermatol Venereol. 2006 Mar;133(3):260-3. doi: 10.1016/s0151-9638(06)70893-6.

引用本文的文献

1
Calciphylaxis due to metastatic well-differentiated neuroendocrine carcinoma.转移性高分化神经内分泌癌所致的钙过敏症
BMJ Case Rep. 2019 Aug 30;12(8):e230951. doi: 10.1136/bcr-2019-230951.
2
Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.慢性肾脏病中钙敏感受体病的治疗:一项系统评价和荟萃分析。
Kidney Int Rep. 2018 Oct 9;4(2):231-244. doi: 10.1016/j.ekir.2018.10.002. eCollection 2019 Feb.
3
Extensive abdominal wall ulceration as a late manifestation of antiphospholipid syndrome: a case report.广泛腹壁溃疡作为抗磷脂综合征的晚期表现:一例报告

本文引用的文献

1
Pre-uremic calciphylaxis.
Iran J Kidney Dis. 2014 May;8(3):252-6.
2
Calciphylaxis: a review.钙过敏:综述
J Am Col Certif Wound Spec. 2011 Mar 27;2(4):66-72. doi: 10.1016/j.jcws.2011.03.001. eCollection 2010 Dec.
3
Update on cutaneous calciphylaxis.皮肤钙化防御的最新进展。
Indian J Dermatol. 2013 Mar;58(2):87-92. doi: 10.4103/0019-5154.108026.
J Med Case Rep. 2018 Aug 14;12(1):226. doi: 10.1186/s13256-018-1753-5.
4
Vascular calcification: When should we interfere in chronic kidney disease patients and how?血管钙化:慢性肾脏病患者何时以及如何进行干预?
World J Nephrol. 2016 Sep 6;5(5):398-417. doi: 10.5527/wjn.v5.i5.398.
5
Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series.钙化性尿毒症小动脉病(钙化防御)的多模式治疗:病例系列
Clin Kidney J. 2016 Feb;9(1):108-12. doi: 10.1093/ckj/sfv120. Epub 2015 Nov 20.
6
Gastrointestinal Bleeding Secondary to Calciphylaxis.钙化防御继发的胃肠道出血
Am J Case Rep. 2015 Nov 17;16:818-22. doi: 10.12659/ajcr.895164.
4
Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.在多介入治疗环境中使用硫代硫酸钠治疗透析患者的钙化防御。
Nephrol Dial Transplant. 2013 May;28(5):1232-40. doi: 10.1093/ndt/gfs548. Epub 2013 Jan 4.
5
Calciphylaxis presenting in early chronic kidney disease with mixed hyperparathyroidism.钙化防御在合并混合性甲状旁腺功能亢进的早期慢性肾病中出现。
Int J Nephrol Renovasc Dis. 2011;4:157-60. doi: 10.2147/IJNRD.S27607. Epub 2011 Dec 20.
6
Parathyroid pathology: hyperparathyroidism and parathyroid tumors.甲状旁腺病理学:甲状旁腺功能亢进和甲状旁腺肿瘤。
Arch Pathol Lab Med. 2010 Nov;134(11):1639-44. doi: 10.5858/2009-0578-CCR.1.
7
Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.钙化尿毒症性小动脉病:病理生理学、活性氧物质和治疗方法。
Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21. doi: 10.4161/oxim.3.2.11354.
8
Calciphylaxis in a cardiac patient without renal disease.一名无肾脏疾病的心脏病患者发生了钙过敏。
Acta Cardiol. 2009 Feb;64(1):91-3. doi: 10.2143/AC.64.1.2034368.
9
Calciphylaxis from nonuremic causes: a systematic review.非尿毒症病因所致的钙过敏症:一项系统综述
Clin J Am Soc Nephrol. 2008 Jul;3(4):1139-43. doi: 10.2215/CJN.00530108. Epub 2008 Apr 16.
10
[Uremic calcifying ateriolopathy (calciphylaxis) with metabolic syndrome and diabetes mellitus. The current perspective].
Nefrologia. 2008;28(1):20-4.